Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement have?
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement has 93 citations in the OpenAlex counts ScholarIQ stores.
When was Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement published?
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement has 2021 year in the ScholarIQ index.
What is the open-access status of Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement?
Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement has gold oa status in the ScholarIQ index.
What is the DOI of Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement?
The DOI for Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement is on the source record.
What is the PMID of Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement?
The PMID for Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement is on the source record.
What is the OpenAlex record for Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement?
The OpenAlex for Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement is on the source record.